Picotamide versus aspirin in diabetic patients with peripheral arterial disease: Has David defeated Goliath?

European Heart Journal

Volumn 25, Issue 20, 2004, Pages 1769-1771

  Gresele, Paolo ^a   Migliacci, Rino ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PICOTAMIDE; PROSTACYCLIN; RAMIPRIL; RIDOGREL; SIMVASTATIN; THROMBOXANE RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR;

ARTERY DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; EDITORIAL; HEART MUSCLE ISCHEMIA; HUMAN; INTERMITTENT CLAUDICATION; MORTALITY; PRIORITY JOURNAL;

ARTERIES; ASPIRIN; DIABETIC ANGIOPATHIES; HUMANS; PERIPHERAL VASCULAR DISEASES; PHTHALIC ACIDS; PLATELET AGGREGATION INHIBITORS;

EID: 4944237227     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.08.008     Document Type: Editorial

References (16)

1. M.A. Creager, D.W. Jones, and J.D. Easton Atherosclerotic vascular disease conference: Writing Group V: medical decision making and therapy Circulation 109 2004 2634 2642
2. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. Brit Med J 2002;324:71-86
3. P. Gresele, and R. Migliacci Extrapolation of trial results suggests that aspirin is useful in intermittent claudication Brit Med J 317 1998 1586 1587
4. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39
5. J. Østergren, P. Sleight, G. Dagenais HOPE study investigators Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease Eur Heart J 25 2004 17 24
6. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22
7. D.L. Bhatt, S.P. Marso, and A.T. Hirsh Amplified benefit of clopidogrel plus aspirin in patients with diabetes mellitus Am J Cardiol 90 2002 625 628
8. M. Sacco, F. Pellegrini, and M.C. Roncaglioni Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in Type 2 diabetic patients. Results of the Primary Prevention Project (PPP) trial Diabetes Care 26 2003 3264 3272
9. G. Davì, I. Catalano, and M. Averna Thromboxane biosynthesis and platelet function in type II diabetes mellitus N Engl J Med 322 1990 1769 1774
10. P. Gresele, G. Guglielmini, and M. De Angelis Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus J Am Coll Cardiol 41 2003 1013 1020
11. G. Davì, P. Gresele, and F. Violi Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo Circulation 96 1997 69 75
12. 2 Circulation 105 2002 1620 1622
13. G. Di Minno, and F. Violi Aspirin resistance and diabetic angiopathy: back to the future Thromb Res 113 2004 97 99
14. G.G.N. Serneri, S. Coccheri, and E. Marubini Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study Eur Heart J 25 2004 1845 1852
15. L. Belhassen, G. Pelle, and J.L. Dubois-Rande Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin J Am Coll Cardiol 41 2003 1198 1204
16. R. Vezza, D. Spina, and R.J. Tallarida Antivasocontrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism Thromb Haemostas 78 1997 1385 1391